Dextrose Monohydrate 50% Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Dextrose Monohydrate 50% Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Jan 13, 2022. Reported reason: Other

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-7517-16
Dosage Form
Injection
Presentation
Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16)
Initial Posting
Jan 13, 2022

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.